The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...
Medically, you don’t have to taper off semaglutide, but many experts recommend it when stopping the medication. Some ...
GLP-1 initiation was common among patients who underwent bariatric surgery, especially sleeve gastrectomy vs Roux-en-Y gastric bypass.
Chemistry researchers at the University of Utah have uncovered an enzyme, dubbed PapB, that can "tie off" therapeutic ...
Henry Meds is a subscription-based telehealth platform that focuses on treatment for endocrine-related conditions. Offerings ...
Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...
A woman's abdominal discomfort turned out to be caused by a build up of food in her stomach. And the treatment involved diet soda.
CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed. In this 26-week, double-blind trial of 72 adults, 36% who ...
GLP-1–pathway agonists such as semaglutide and newer multi-agonists have transformed care for obesity and diabetes, yet developers still wrestle with durability, tissue targeting, and signal "bias." ...
A study presented at the European Congress of Cardiology links GLP-1 drugs with a reduction in hospitalizations and deaths ...
A new class of weight-loss drug has shown it can significantly boost weight loss when paired with GLP-1 therapy – without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback